PlexBio Co., Ltd.
6572
Rank in Stocks
#26503
PlexBio Co., Ltd. is dedicated to the creation and production of in vitro... PlexBio Co., Ltd. is dedicated to the creation and production of in vitro diagnostic (IVD) solutions for both molecular biology and immunology purposes. Their comprehensive product range features services for optimizing diagnostic workflows, as well as automated kits for sample preparation and extraction. A key innovation is their IntelliPlex platform, which leverages pCode technology to enable advanced, "sample-to-answer" multiplexing assays. The company also supplies specialized oncology panels designed for detecting lung cancer, gene mutations, and chromosomal rearrangements. Additionally, PlexBio offers a variety of infectious disease tests, including IntelliPlex kits for SARS-CoV-2 detection, influenza, and SARS-CoV-2 variant analysis, complemented by essential reagents such as pCode coupling buffer sets. Founded in 2009, PlexBio Co., Ltd. operates from its headquarters in Taipei, Taiwan.
Share Price
$0.19174725
Last synced: 2026-11-10
Market Cap
$19.87M
Change (1 day)
-2.78%
Change (1 year)
-34.69%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade PlexBio Co., Ltd. (6572)
Category
Healthcare
Operating Margin for PlexBio Co., Ltd. (6572)
Operating Margin as of November 2026 TTM: -39.77%
According to PlexBio Co., Ltd.'s latest financial reports, its current operating margin (TTM) is -39.77%. At the end of 2025 the company had an operating margin of -51.65%.
Operating Margin history for PlexBio Co., Ltd. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -39.77% | -23.00% |
| 2025 | -51.65% | -16.83% |
| 2024 | -62.10% | 61.85% |
| 2023 | -38.37% | 9.60% |
| 2022 | -35.01% | -67.66% |
| 2021 | -108.26% | -26.02% |
| 2020 | -146.34% | 0.00% |
| 2019 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 28.37% | -100.71% |
US
|
|
| 12.36% | -100.31% |
FR
|
|
| 9.83% | -100.25% |
US
|
|
| 31.11% | -100.78% |
JP
|
|
| 9.87% | -100.25% |
CH
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about PlexBio Co., Ltd.'s operating margin
What is PlexBio Co., Ltd.'s operating margin?
PlexBio Co., Ltd.'s operating margin is -39.77%, as of Nov 2026.
What was PlexBio Co., Ltd.'s operating margin in 2025?
In 2025, PlexBio Co., Ltd.'s operating margin was -51.65%, compared with -62.10% in 2024.
How has PlexBio Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, PlexBio Co., Ltd.'s operating margin was highest in 2022 (-35.01%) and lowest in 2020 (-146.34%).
How does PlexBio Co., Ltd.'s operating margin compare with similar companies?
PlexBio Co., Ltd.'s operating margin (-39.77%) is lower than that of all 5 similar companies listed above. The highest among them is HOYA Corporation, with 31.11%.